Neurocrine Biosciences
NBIX
#1492
Rank
$9.84 B
Marketcap
$101.22
Share price
2.03%
Change (1 day)
7.97%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividends for this company